Commentary

Barriers to Biologics [editorial]

Cutis. 2004 September;74(3):164
By
Weinberg JM
Author and Disclosure Information

No abstract available.
PDF Download

 

Recommended Reading

Trachyonychia: A Case Report and Review of Manifestations, Associations, and Treatments
MDedge Dermatology
Biologic Therapy for Psoriasis: The Tumor Necrosis Factor Inhibitors—Infliximab and Etanercept
MDedge Dermatology
Biologic Therapy for Psoriasis: The T-Cell–Targeted Therapies—Efalizumab and Alefacept
MDedge Dermatology
Epidemiology of Skin Diseases in People of Color
MDedge Dermatology
Picking Apart the Picker: A Clinician's Guide for Management of the Patient Presenting With Excoriations
MDedge Dermatology
Successful Treatment of Recalcitrant Palmoplantar Psoriasis With Etanercept
MDedge Dermatology
The Köbner Phenomenon and Psoriatic Arthritis
MDedge Dermatology
Should Coal Tar Products Carry Cancer Warnings?
MDedge Dermatology
Deep Venous Thrombosis After High-Dose Intravenous Immunoglobulin in the Treatment of Pemphigus Vulgaris
MDedge Dermatology
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease Management
MDedge Dermatology